{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T04:24:42Z","timestamp":1773548682098,"version":"3.50.1"},"reference-count":30,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncology Practice"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec><jats:title>PURPOSE:<\/jats:title><jats:p> Omic-informed therapy is being used more frequently for patients with non\u2013small-cell lung cancer (NSCLC) being treated on the basis of evidence-based decision-making. However, there is a lack of a standardized framework to evaluate those decisions and understand the association between omics-based management strategies and survival among patients. Therefore, we compared outcomes between patients with lung adenocarcinoma who received omics-driven targeted therapy versus patients who received standard therapeutic options. <\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS AND METHODS:<\/jats:title><jats:p> This was a retrospective study of patients with advanced NSCLC adenocarcinoma (N = 798) at City of Hope who received genomic sequencing at the behest of their treating oncologists. A thoracic oncology registry was used as a clinicogenomic database to track patient outcomes. <\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p> Of 798 individuals with advanced NSCLC (median age, 65 years [range, 22-99 years]; 60% white; 50% with a history of smoking), 662 patients (83%) had molecular testing and 439 (55%) received targeted therapy on the basis of the omic-data. A fast-and-frugal decision tree (FFT) model was developed to evaluate the impact of omics-based strategy on decision-making, progression-free survival (PFS), and overall survival (OS). We calculated that the overall positive predictive value of the entire FFT strategy for predicting decisions regarding the use of tyrosine kinase inhibitor\u2013based targeted therapy was 88% and the negative predictive value was 96%. In an adjusted Cox regression analysis, there was a significant correlation with survival benefit with the FFT omics-driven therapeutic strategy for both PFS (hazard ratio [HR], 0.56; 95% CI, 0.42 to 0.74; P &lt; .001) and OS (HR, 0.51; 95% CI, 0.36 to 0.71; P &lt; .001) as compared with standard therapeutic options. <\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION:<\/jats:title><jats:p> Among patients with advanced NSCLC who received care in the academic oncology setting, omics-driven therapy decisions directly informed treatment in patients and was correlated with better OS and PFS. <\/jats:p><\/jats:sec>","DOI":"10.1200\/op.20.00117","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T19:59:25Z","timestamp":1594238365000},"page":"e257-e265","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of Omics-Based Strategies for the Management of Advanced Lung Cancer"],"prefix":"10.1200","volume":"17","author":[{"given":"Ravi","family":"Salgia","sequence":"first","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa","family":"Mambetsariev","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Pharaon","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Fricke","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel Ray","family":"Baroz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iztok","family":"Hozo","sequence":"additional","affiliation":[{"name":"Department of Mathematics, Indiana University Northwest, Gary, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Applied AI and Data Science, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Koczywas","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erminia","family":"Massarelli","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Reckamp","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA"},{"name":"Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Djulbegovic","sequence":"additional","affiliation":[{"name":"Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.12.001"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810699"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00077-2"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406766"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714448"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2018.0046"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0059"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.17.00033"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.019836"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12895"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12490"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713137"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0489"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0348"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.11058"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-2935"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv276"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2019.11.006"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30608-3"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24353"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0178"},{"key":"B26","volume":"107","author":"Jardim DL","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.5997"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.2129"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25643"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_237863"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00188-6"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0380"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3241"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.6879"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP.20.00117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T10:20:49Z","timestamp":1653819649000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP.20.00117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1200\/OP.20.00117"],"URL":"https:\/\/doi.org\/10.1200\/op.20.00117","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"2020-06-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}